HomeInsightsStock Comparison

Divis Laboratories Ltd vs Vilin Bio Med Ltd Stock Comparison

Divis Laboratories Ltd vs Vilin Bio Med Ltd Stock Comparison

Last Updated on: Jul 19, 2025

Key Highlights

  • The Latest Trading Price of Divis Laboratories Ltd is ₹ 6730 as of 18 Jul 15:30.
  • The P/E Ratio of Divis Laboratories Ltd changed from 38.3 on March 2020 to 69.8 on March 2025 . This represents a CAGR of 10.52% over 6 yearsThe P/E Ratio of Vilin Bio Med Ltd changed from 0 on March 2020 to 0 on March 2025 . This represents a CAGR of 0.0% over 6 years.
  • The Market Cap of Divis Laboratories Ltd changed from ₹ 52763 crore on March 2020 to ₹ 153257 crore on March 2025 . This represents a CAGR of 19.45% over 6 yearsThe Market Cap of Vilin Bio Med Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 6 years.
  • The revenue of Divis Laboratories Ltd for the Mar '25 is ₹ 2671 crore as compare to the Dec '24 revenue of ₹ 2401 crore. This represent the growth of 11.25% The revenue of Vilin Bio Med Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 revenue of ₹ 0 crore. This represent the decline of 0%.
  • The ebitda of Divis Laboratories Ltd for the Mar '25 is ₹ 971 crore as compare to the Dec '24 ebitda of ₹ 825 crore. This represent the growth of 17.7% The ebitda of Vilin Bio Med Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 ebitda of ₹ 0 crore. This represent the decline of 0%.
  • The net profit of Divis Laboratories Ltd changed from ₹ 356 crore to ₹ 662 crore over 8 quarters. This represents a CAGR of 36.37% The net profit of Vilin Bio Med Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% .
  • The Dividend Payout of Divis Laboratories Ltd changed from 33.04 % on March 2020 to 50.44 % on March 2024 . This represents a CAGR of 8.83% over 5 yearsThe Dividend Payout of Vilin Bio Med Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Divis Laboratories Ltd

  • Divi's Laboratories Limited is one of the leading pharmaceutical companies in the world, manufacturing Active Pharmaceutical Ingredients (APIs), Intermediates and Nutraceuticals.
  • The Company is one of the world's largest API companies, with two manufacturing units and a market presence across 100 countries.
  • It is engaged in the manufacture of Active Pharmaceutical ingredients (API's), Intermediates and Nutraceutical ingredients with predominance in exports.
  • In addition to generic business, the Company, through its custom synthesis business, supports innovator pharma companies for their patented products business right from gram scale requirements for clinical trials to launch as well as late life cycle management.
  • It is among the largest pharmaceutical companies in India with a portfolio of approx.

About Vilin Bio Med Ltd

  • Vilin Bio Med Limited was originally incorporated on June 29, 2005, which commenced business on July 11, 2005 issued by Registrar of Companies, Andhra Pradesh, Hyderabad.
  • The Company started its first commercial production in year 2006.
  • In 2007, the Company expanded the Phase 2 for Beta Lactum facility with 16000 sft for Tablet, Capsule and Dry Syrup sections.
  • In 2010, it acquired more than 1000 molecules Drug Approvals with different strengths in therapeutics of Diabetic, Neuro and Cardio. The Company added the Sachet section in Non-Beta Lactum facility in 2014.
  • The Company allotted a fresh issue of 40,00,000 Equity Shares of Rs 10/- each by its Initial Public Offering by raising funds aggregating to Rs 12 Crore on June 7, 2023 to the Public. At present, Company is engaged in domestic business of manufacturing Pharmaceuticals products and the Manufacturing Unit is located in Roorkee, in the State of Uttarakhand.

Divis Laboratories Ltd News Hub

News

Divis Laboratories Ltd up for third consecutive session

Divis Laboratories Ltd is up for a third straight session today. The stock is quoting at R...

Read more

11 Jun 2025 13:05

News

Divis Laboratories Ltd down for fifth straight session

Divis Laboratories Ltd is down for a fifth straight session today. The stock is quoting at...

Read more

02 Jun 2025 13:35

News

Divis Lab inks long-term global pharma deal

As part of the agreement, Divis will manufacture and supply advanced pharmaceutical interm...

Read more

24 May 2025 10:06

News

Divis Lab enters into a LT manufacturing and supply agreement with a global pharma co.

Divis Laboratories has entered into a long term manufacturing and supply agreement with a ...

Read more

24 May 2025 11:34

News

Divis Lab gains after Q4 PAT climbs 23% YoY; recommends final dividend of Rs 30/ share

Revenue from operations grew by 12.24% year on year (YoY) to Rs 2,585 crore in the quarter...

Read more

19 May 2025 10:00

News

Divis Laboratories to convene AGM

Divis Laboratories announced that the 35th Annual General Meeting(AGM) of the company will...

Read more

19 May 2025 17:49

Vilin Bio Med Ltd News Hub

News

Vilin Bio Med to conduct board meeting

Vilin Bio Med will hold a meeting of the Board of Directors of the Company on 17 May 2025....

Read more

12 May 2025 10:32

News

Vilin Bio Med announces board meeting date

Vilin Bio Med will hold a meeting of the Board of Directors of the Company on 10 January 2...

Read more

06 Jan 2025 12:56

News

Vilin Bio Med to hold AGM

Vilin Bio Med announced that the 18th Annual General Meeting (AGM) of the company will be ...

Read more

14 Sep 2024 10:29

News

Vilin Bio Med announces board meeting date

Vilin Bio Med will hold a meeting of the Board of Directors of the Company on 22 August 20...

Read more

17 Aug 2024 10:21

News

Vilin Bio Med to table results

Vilin Bio Med will hold a meeting of the Board of Directors of the Company on 29 May 2024 ...

Read more

24 May 2024 13:45

News

Vilin Bio Med to discuss results

Vilin Bio Med will hold a meeting of the Board of Directors of the Company on 8 February 2...

Read more

03 Feb 2024 13:01

SWOT Analysis Of Divis Laboratories Ltd

Strength

4

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of Vilin Bio Med Ltd

Strength

0

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Divis Laboratories Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Vilin Bio Med Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Divis Laboratories Ltd and Vilin Bio Med Ltd

Which company has a larger market capitalization, Divis Laboratories Ltd or Vilin Bio Med Ltd?

Market cap of Divis Laboratories Ltd is 178,672 Cr while Market cap of Vilin Bio Med Ltd is 35 Cr

What are the key factors driving the stock performance of Divis Laboratories Ltd and Vilin Bio Med Ltd?

The stock performance of Divis Laboratories Ltd and Vilin Bio Med Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Divis Laboratories Ltd and Vilin Bio Med Ltd?

As of July 19, 2025, the Divis Laboratories Ltd stock price is INR ₹6730.45. On the other hand, Vilin Bio Med Ltd stock price is INR ₹25.7.

How do dividend payouts of Divis Laboratories Ltd and Vilin Bio Med Ltd compare?

To compare the dividend payouts of Divis Laboratories Ltd and Vilin Bio Med Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions